Ling Yan
Papers
1
Total Citations
7
H-Index
1
About
Dr. Ling Yan is a cardiovascular researcher whose work focuses on the inflammatory and metabolic pathways underlying cardiac surgery outcomes, particularly in vulnerable populations. Her major contributions center on the role of the receptor for advanced glycation endproducts (RAGE) and its ligand S100A12 as biomarkers of postoperative recovery. In her highly cited 2013 study, Dr. Yan demonstrated that elevated plasma levels of S100A12 and soluble RAGE (sRAGE) are significantly associated with prolonged hospitalization following non-urgent coronary artery bypass grafting. This work, which has garnered 7 citations, provided early clinical evidence linking these molecular markers to the systemic inflammatory response triggered by cardiopulmonary bypass. By identifying these biomarkers, Dr. Yan has helped pave the way for risk stratification and personalized perioperative care in cardiac surgery. Her research is particularly notable for its focus on pediatric and adult cardiac populations, bridging insights from both fields. Dr. Yan’s findings continue to inform studies on inflammation-driven complications, making her a respected voice in translational cardiovascular medicine.
Research Focus
Key Achievements
Top Papers
- 1